Fallowfield, L <br/><br/>
Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study.  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Apr 2015 
 - 166-70 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1532-3080 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2015.01.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous--psychology<br/>Antineoplastic Agents--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cross-Over Studies<br/>Female<br/>Humans<br/>Injections, Subcutaneous--psychology<br/>Patient Preference--psychology<br/>Patient Satisfaction<br/>Trastuzumab--administration & dosage